ISSN: 2329-9495
+44 1478 350008
Department of Cardiology, State Key Laboratory of Frigid Zone Cardiovascular Diseases, General Hospital of Northern Theater Command, Liaoning Province, China
Research Article
Oral Soluble Guanylate Cyclase Stimulators in Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Author(s): Qiang Ren, Quanyu Zhang* and Sicong Ma*
Background: The impact of Guanylate Cyclase (sGC) stimulators on clinical outcomes of HF patients were still controversial.
Objectives: To investigate the efficacy and safety of oral soluble sGC stimulators in Heart Failure (HF).
Methods: PubMed, Web of Science, and Cochrane Library were searched to identify Randomized Controlled Trials (RCTs) comparing sGC stimulators vs placebo in HF patients. A total of 6 RCTs with 7382 HF patients were included.
Results: Compared with placebo, oral sGC stimulators reduced the risk of a composite of Cardiovascular (CV) death or Hospitalization for HF (HHF), Odd’s Ratio (OR) 0.87, 95% Confidence Interval (CI) 0.78-0.98, p=0.02), and CV death [OR 0.45, 95% CI 0.38-0.53, p<0.001]. Significant reduction in the CV death [OR 0.42, 95% .. View More»